Perspective - (2025) Volume 10, Issue 3
Received: 01-May-2025, Manuscript No. jncr-25-190081;
Editor assigned: 05-May-2025, Pre QC No. P-190081;
Reviewed: 19-May-2025, QC No. Q-190081;
Revised: 22-May-2025, Manuscript No. R-190081;
Published:
29-May-2025
, DOI: 10.37421/2572-0813.2025.10.298
Citation: Sato, Hana. ”Advancements in Ultra-Sensitive Nanomaterial Biosensors.” J Nanosci Curr Res 10 (2025):298.
Copyright: © 2025 Sato H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
The field of ultra-sensitive biosensing is experiencing rapid advancements, driven by the critical need for early disease diagnosis and personalized medicine. Nanomaterials have emerged as pivotal components in this domain, offering unique properties that enable unprecedented levels of sensitivity and selectivity. This review encapsulates the development and application of ultra-sensitive nano-sensors designed for real-time biomarker detection, underscoring breakthroughs in nanomaterial synthesis and sensing mechanisms, particularly when integrated with microfluidics to facilitate early disease identification and tailored medical treatments. The primary objective is to achieve superior sensitivity and selectivity for a wide array of clinically significant biomarkers through sophisticated nano-sensor designs [1].
Graphene-based field-effect transistors (GFETs) represent a promising platform for highly sensitive biomarker detection due to graphene's tunable electronic properties, which allow for substantial signal amplification upon biomarker binding. This characteristic makes GFETs particularly suitable for the early diagnosis of cancer, although challenges related to achieving high specificity and mitigating matrix effects still require focused research and development to fully realize their potential in clinical settings [2].
Plasmonic nanoparticles, when functionalized with antibodies, have demonstrated remarkable efficacy in electrochemical biosensors for detecting specific biomarkers like cardiac troponin I. The unique nanostructure of these systems significantly enhances the electrochemical signal, enabling detection limits in the femtomolar range, and their rapid response time positions them as strong candidates for point-of-care diagnostic applications [3].
Quantum dots (QDs) are being increasingly utilized as fluorescent probes in sophisticated immunoassay formats, such as sandwich assays, for the detection of key biomarkers associated with diseases like Alzheimer's. The inherent photostability and tunable emission spectra of QDs are crucial for achieving sensitive, multiplexed detection, thereby improving diagnostic accuracy and enabling the identification of disease at earlier stages [4].
A novel approach involving nano-imprinted polymer sensors has been developed for the highly sensitive and specific detection of viral RNA sequences. These sensors leverage a high surface area and precisely engineered recognition sites within the nano-imprint structure to enhance both sensitivity and specificity, facilitating the rapid and reliable identification of pathogens [5].
The integration of aptamers with gold nanoparticles (AuNPs) has led to the creation of highly sensitive colorimetric sensors for biomarkers such as prostate-specific antigen (PSA). The inherent strong binding affinity of aptamers, combined with the advantageous optical properties of AuNPs, enables rapid, label-free detection with a simple visual readout, making it a user-friendly diagnostic tool [6].
Metal-organic frameworks (MOFs) are being explored as versatile platforms for the electrochemical sensing of neurotransmitters. Their exceptionally high porosity and extensive surface area are ideal for loading catalytic nanoparticles, which in turn leads to significantly improved sensitivity and selectivity, particularly in the detection of neurotransmitters like dopamine, crucial for neurological health monitoring [7].
Microfluidic chips incorporating silicon nanowire transistors have been engineered for the ultrasensitive detection of microRNAs. The substantial surface area provided by the nanowires facilitates efficient hybridization with target microRNAs and amplifies electrical signals upon binding, offering a powerful tool for early cancer diagnosis by detecting these critical genetic markers [8].
Antibody-functionalized carbon nanotube field-effect transistors (CNTFETs) are being developed for the sensitive detection of specific viruses, such as the influenza virus. The exceptional charge carrier mobility of carbon nanotubes, coupled with the high specificity of antibody-antigen interactions, results in rapid and highly sensitive detection capabilities [9].
Finally, a novel biosensor design employing mesoporous silica nanoparticles decorated with enzymes has been presented for the rapid and sensitive detection of glucose. The large surface area of the mesoporous silica structure facilitates enhanced enzyme immobilization, leading to improved catalytic activity and more efficient signal transduction for accurate glucose monitoring [10].
The advancement of ultra-sensitive nano-sensors is fundamentally reshaping diagnostic capabilities, particularly for real-time biomarker detection. This technological frontier is characterized by innovative nanomaterial synthesis, sophisticated sensing mechanisms, and synergistic integration with microfluidic systems. The overarching goal is to facilitate earlier disease diagnosis and enable truly personalized medicine by achieving remarkable sensitivity and selectivity for a diverse range of clinically relevant biomarkers [1].
Graphene field-effect transistors (GFETs) are emerging as a powerful tool for ultrasensitive biomarker detection. Their unique tunable electronic properties allow for significant signal amplification when biomarkers bind to the graphene surface, making them ideal for early cancer diagnostics. While challenges related to specificity and matrix effects are acknowledged, ongoing research aims to overcome these hurdles for broader clinical application [2].
Plasmonic nanoparticles, when conjugated with antibodies, are being employed in electrochemical biosensors for highly sensitive detection of biomarkers like cardiac troponin I. This nanostructure significantly amplifies electrochemical signals, achieving femtomolar detection limits and demonstrating rapid response times, which are critical for potential point-of-care applications in cardiac diagnostics [3].
Quantum dots (QDs) are proving to be invaluable as fluorescent probes in advanced immunoassay formats, such as sandwich assays, for detecting biomarkers associated with neurodegenerative diseases like Alzheimer's. The inherent photostability and precisely controllable emission wavelengths of QDs are instrumental in enabling sensitive and multiplexed detection, thus enhancing diagnostic accuracy [4].
A promising development in pathogen detection involves nano-imprinted polymer sensors designed for the ultrasensitive and specific identification of viral RNA sequences. These sensors utilize a high surface area and meticulously engineered recognition sites within the nano-imprint to achieve enhanced sensitivity and specificity, crucial for rapid outbreak identification and monitoring [5].
The combination of aptamers and gold nanoparticles (AuNPs) has led to the development of highly sensitive colorimetric sensors for detecting biomarkers such as prostate-specific antigen (PSA). The strong binding affinity of aptamers, coupled with the distinctive optical properties of AuNPs, facilitates rapid, label-free detection with a simple visual readout, offering a user-friendly diagnostic approach [6].
Metal-organic frameworks (MOFs) are being investigated as effective platforms for electrochemical sensing of neurotransmitters. Their exceptionally high porosity and vast surface area enable superior loading of catalytic nanoparticles, resulting in marked improvements in sensitivity and selectivity for detecting crucial neurotransmitters like dopamine [7].
Microfluidic chips integrated with silicon nanowire transistors are demonstrating remarkable performance in the ultrasensitive detection of microRNAs. The large surface area of the nanowires enhances target microRNA hybridization and signal amplification, providing a sensitive method for early cancer diagnosis through the detection of specific microRNA profiles [8].
Antibody-functionalized carbon nanotube field-effect transistors (CNTFETs) are being engineered for the sensitive detection of viruses like influenza. The superior charge carrier mobility of carbon nanotubes, combined with the specificity of antibody-antigen interactions, enables rapid and highly sensitive virus detection [9].
Lastly, a novel biosensor employing mesoporous silica nanoparticles functionalized with enzymes has been developed for sensitive and rapid glucose detection. The extensive surface area of the mesoporous silica structure optimizes enzyme immobilization, leading to enhanced catalytic efficiency and improved signal transduction for accurate glucose monitoring [10].
This collection of research highlights significant advancements in ultra-sensitive nano-sensors for real-time biomarker detection. Studies showcase the application of various nanomaterials, including graphene, plasmonic nanoparticles, quantum dots, nano-imprinted polymers, aptamer-functionalized gold nanoparticles, metal-organic frameworks, silicon nanowires, carbon nanotubes, and mesoporous silica nanoparticles. These technologies enable highly sensitive and specific detection of diverse biomarkers such as cancer markers, cardiac troponin, viral RNA, PSA, neurotransmitters, microRNAs, influenza viruses, and glucose. The integration with microfluidics and electrochemical or fluorescent detection methods aims to improve early disease diagnosis, personalized medicine, and point-of-care applications.
None
None
Journal of Nanosciences: Current Research received 387 citations as per Google Scholar report
